ArticleJournal of inflammation research2024

Comparative Efficacy and Safety of Ustekinumab and Secukinumab in the Treatment of Generalized Pustular Psoriasis: A 48-Week Retrospective Cohort Study with Genetic Background Analysis.

Shi-Fan Ruan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.